Sorin Group Introduces OVATIO Implantable Cardioverter Defibrillators in Europe

The Sorin Group, a global leader in medical technologies for cardiac surgery, has announced the European introduction of OVATIO, a new family of implantable cardioverter defibrillators (ICDs). OVATIO DR and OVATIO VR are designed to detect and convert life-threatening arrhythmias, preventing sudden cardiac arrest, which is the leading cause of death in Europe, estimated at 400,000 deaths annually. OVATIO ICDs are the world's smallest, with a size of 29 cc and a thickness of 11 mm, and offer 34 joules of maximum output.

Key Takeaways:

• OVATIO DR and OVATIO VR are the first dual-chamber ICDs to offer AAIsafeR, a pacing mode that limits unnecessary stimulation in the right ventricle, reducing the risk of heart failure.
• AAIsafeR reduces ventricular pacing to less than 0.2 percent in ICD patients with intrinsic conduction, compared to 50 percent for conventional dual-chamber ICDs.
• PARAD+, a ventricular arrhythmia detection software, has a 99 percent overall specificity in diagnosing supraventricular tachyarrhythmias (SVTs), reducing the number of inappropriate shocks.
• OVATIO ICDs can detect and treat the full spectrum of tachyarrhythmias through painless anti-tachycardia pacing (ATP), offering ICD patients the comfort of painless therapy.
• The OVATIO family includes innovative features, such as advanced diagnostic capabilities and a user-friendly programming software that shortens follow-up time.
• The introduction of OVATIO reflects Sorin Group's drive to develop cutting-edge tachyarrhythmia management systems that simplify implant and follow-up procedures.

Statistics:

• OVATIO ICDs are only 29 cc in size and 11 mm in thickness.
• Estimated 400,000 deaths due to sudden cardiac arrest in Europe annually.
• 55-69% of inappropriate shocks are triggered by supraventricular tachyarrhythmias (SVTs) (Source: Prasad et al., Indian Heart Journal, 1997).
• OVATIO DR demonstrated a 99% overall specificity with out-of-the-box settings in a study published in PACE (Source: Hintringer et al., 2004).
• The OVATIO DR ICD can detect and treat ventricular tachyarrhythmias up to 255 bpm.

Sources:

• Prasad K, et al. Inappropriate Shocks in Patients Receiving Internal Cardioverter-Defibrillators for Maligant Ventricular Arrhythmias. Indian Heart Journal. July-Aug. 1997
• Korte T, et al. High Incidence of Appropriate and Inappropriate ICD Therapies in Children and Adolescents with Implantable Defibrillator. PACE July 2004
• Hintringer F, et al. Comparison of the Specificity of Implantable Dual Chamber Defibrillator Detection Algorithms. PACE, 2004, vol.27: 976-982
• Source: Sorin Group CONTACT: Francesca Caprari, Director, Communications & Industry Affairs
• ASIA PULSE 19-01 1200